Clark John, White Deborah, Daubney Esther, Curran Martin, Bousfield Rachel, Gouliouris Theodore, Powell Elizabeth, Palmer Adam, Agrawal Shruti, Inwald David, Kean Iain, Török M Estée, Baker Stephen, Pathan Nazima
Department of Paediatrics, University of Cambridge, Cambridge, Cambridgeshire, CB2 0QQ, UK.
Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, CB2 0QQ, UK.
Wellcome Open Res. 2022 Mar 3;6:119. doi: 10.12688/wellcomeopenres.16848.2. eCollection 2021.
Broad-spectrum antimicrobial therapy is a key driver of antimicrobial resistance. Here, we aimed to review indications for antimicrobial therapy, determine the proportion of suspected bacterial infections that are confirmed by culture, and assess the time taken for microbiology test results to become available in the paediatric intensive care unit (PICU). : A single-centre prospective observational cohort study of 100 consecutive general PICU admissions from 30 October 2019 to 19 February 2020. Data were collected from the hospital medical record and entered into a study database prior to statistical analysis using standard methods. : Of all episodes of suspected infection, 22% of lower respiratory tract infection, 43% of bloodstream and 0% of central nervous system infection were associated with growth on microbiology culture. 90% of children received antimicrobial therapy. Hospital-acquired infection occurred less commonly than primary infection, but an organism was grown in a greater proportion (64%) of cultures. Final laboratory reports for negative cultures were issued at a median of 120.3 hours for blood cultures and 55.5 hours for endotracheal tube aspirate cultures. : Despite most critically children receiving antimicrobial therapy, infection was often not microbiologically confirmed. Novel molecular diagnostics may improve rationalisation of treatment in this population.
广谱抗菌治疗是抗菌药物耐药性的关键驱动因素。在此,我们旨在回顾抗菌治疗的适应症,确定通过培养确诊的疑似细菌感染的比例,并评估儿科重症监护病房(PICU)中微生物检测结果可得所需的时间。:一项单中心前瞻性观察性队列研究,研究对象为2019年10月30日至2020年2月19日期间连续入住普通PICU的100名患者。数据从医院病历中收集,并在使用标准方法进行统计分析之前录入研究数据库。:在所有疑似感染病例中,22%的下呼吸道感染、43%的血流感染和0%的中枢神经系统感染与微生物培养生长有关。90%的儿童接受了抗菌治疗。医院获得性感染的发生率低于原发性感染,但在更大比例(64%)的培养物中培养出了病原体。血培养阴性培养物的最终实验室报告发布时间中位数为120.3小时,气管内吸出物培养为55.5小时。:尽管大多数重症儿童接受了抗菌治疗,但感染往往未得到微生物学证实。新型分子诊断方法可能会改善该人群治疗的合理性。